Sharade Pailoor, MD | |
1 Medical Center Dr, Biddeford, ME 04005-9422 | |
(207) 283-7075 | |
Not Available |
Full Name | Sharade Pailoor |
---|---|
Gender | Female |
Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
Location | 1 Medical Center Dr, Biddeford, Maine |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1528131117 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | MD9632 (Maine) | Primary |
Mailing Address | Practice Location Address |
---|---|
Sharade Pailoor, MD 324 Gannett Dr Ste 200, South Portland, ME 04106-3266 Ph: (207) 482-7800 | Sharade Pailoor, MD 1 Medical Center Dr, Biddeford, ME 04005-9422 Ph: (207) 283-7075 |
News Archive
Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today its intent to launch a prescription analgesic, Nyloxin Rx, for the treatment of severe (Stage 3) chronic pain.
Immune Design Corp. (IDC), a privately held biotechnology company developing novel vaccines and immunotherapies for infectious disease and cancer, announced today that it has entered into a license and development agreement with MedImmune for the use and commercialization of IDC's proprietary Glucopyranosyl Lipid Adjuvant (GLA) as a component in vaccines for select infectious diseases.
Ten young researchers were named Pew Latin American Fellows in the Biomedical Sciences today by The Pew Charitable Trusts. For these scientists, who have dedicated their careers to finding solutions for some of the world's most troubling health problems, this fellowship will provide support that will further their research, enable them to work with colleagues in the United States, and increase scientific knowledge throughout their home region.
Based on preliminary results, the study authors found that elderly people with high lifetime exposure to secondhand smoke were approximately 30 percent more likely to develop dementia than those with no lifetime secondhand smoke exposure.April 28, May 5, 2007.
› Verified 4 days ago